南方科技大学知识苑(SUSTech KC): Human neutralizing antibodies elicited by SARS-CoV-2 infection

Title	Human neutralizing antibodies elicited by SARS-CoV-2 infection
Author	Ju，Bin 1,2; Zhang，Qi 3; Ge，Jiwan 4; Wang，Ruoke 3; Sun，Jing 5; Ge，Xiangyang 1; Yu，Jiazhen 1; Shan，Sisi 3; Zhou，Bing 1; Song，Shuo 1; Tang，Xian 1; Yu，Jinfang 4; Lan，Jun 4; Yuan，Jing 6; Wang，Haiyan 1; Zhao，Juanjuan 1,2; Zhang，Shuye 7; Wang，Youchun 8; Shi，Xuanling 3; Liu，Lei 1,2 ; Zhao，Jincun 5; Wang，Xinquan 4; Zhang，Zheng 1,2 ; Zhang，Linqi 3
Corresponding Author	Zhang，Zheng
Publication Years	2020
DOI	10.1038/s41586-020-2380-z
Source Title	NATURE Impact Factor & Quartile
ISSN	0028-0836
EISSN	1476-4687
Volume	584 Issue:7819Pages:115-+
Abstract	The emerging coronavirus SARS-CoV-2 pandemic presents a global health emergency in urgent need of interventions. SARS-CoV-2 entry into the target cells depends on binding between the receptor-binding domain (RBD) of the viral Spike protein and the ACE2 cell receptor. Here, we report the isolation and characterization of 206 RBD-specific monoclonal antibodies derived from single B cells of eight SARS-CoV-2 infected individuals. We identified antibodies with potent anti-SARS-CoV-2 neutralization activity that correlates with their competitive capacity with ACE2 for RBD binding. Surprisingly, neither the anti-SARS-CoV-2 antibodies nor the infected plasma cross-reacted with SARS-CoV or MERS-CoV RBDs, although substantial plasma cross-reactivity to their trimeric Spike proteins was found. Crystal structure analysis of RBD-bound antibody revealed steric hindrance that inhibits viral engagement with ACE2 and thereby blocks viral entry. These findings suggest that anti-RBD antibodies are viral species-specific inhibitors. The antibodies identified here may be candidates for the development of SARS-CoV-2 clinical interventions.
URL	[Source Record]
Indexed By	SCI
Language	English
Important Publications	NI Journal Papers ; NI论文 ; ESI Highly Cited Papers ; ESI Highly Cited Papers ; ESI Highly Cited Papers ; ESI Highly Cited Papers ; ESI Highly Cited Papers ; ESI Highly Cited Papers ; ESI Highly Cited Papers ; ESI Highly Cited Papers ; ESI Highly Cited Papers ; ESI Highly Cited Papers ; ESI Highly Cited Papers
SUSTech Authorship	Corresponding
Funding Project	Science and Technology Innovation Committee of Shenzhen Municipality[202002073000002] ; Tsinghua University Initiative Scientific Research Program[20201080053] ; National Beijing Municipal Science and Technology Commission[171100000517-001][171100000517-003] ; National Key Plan for Scientific Research and Development of China[2016YFD0500307]
WOS Research Area	Science & Technology - Other Topics
WOS Subject	Multidisciplinary Sciences
WOS Accession No	WOS:000554511300002
Publisher	NATURE PUBLISHING GROUP
ESI Research Field	BIOLOGY & BIOCHEMISTRY;CLINICAL MEDICINE;MULTIDISCIPLINARY;PLANT & ANIMAL SCIENCE;ENVIRONMENT/ECOLOGY;SOCIAL SCIENCES, GENERAL;MICROBIOLOGY;ECONOMICS BUSINESS;IMMUNOLOGY;MATERIALS SCIENCE;COMPUTER SCIENCE;SPACE SCIENCE;MOLECULAR BIOLOGY & GENETICS;CHEMISTRY;NEUROSCIENCE & BEHAVIOR;PHYSICS;GEOSCIENCES;ENGINEERING
Scopus EID	2-s2.0-85085949737
Data Source	Scopus
Citation statistics	Cited Times [WOS]:943
Document Type	Journal Article
Identifier	http://kc.sustech.edu.cn/handle/2SGJ60CL/140054
Department	School of Medicine 南方科技大学第二附属医院
Affiliation	1.Institute for Hepatology,National Clinical Research Center for Infectious Disease,Shenzhen Third People’s Hospital,Shenzhen,518112,China 2.The Second Affiliated Hospital,School of Medicine,Southern University of Science and Technology,Shenzhen,518055,China 3.Center for Global Health and Infectious Diseases,Comprehensive AIDS Research Center,and Beijing Advanced Innovation Center for Structural Biology,School of Medicine,Tsinghua University,Beijing,100084,China 4.The Ministry of Education Key Laboratory of Protein Science,Beijing Advanced Innovation Center for Structural Biology,Beijing Frontier Research Center for Biological Structure,Collaborative Innovation Center for Biotherapy,School of Life Sciences,Tsinghua University,Beijing,100084,China 5.State Key Laboratory of Respiratory Disease,National Clinical Research Center for Respiratory Disease,Guangzhou Institute of Respiratory Health,the First Affiliated Hospital of Guangzhou Medical University,Guangzhou,510182,China 6.Department for Infectious Diseases,Shenzhen Third People’s Hospital,Shenzhen,518112,China 7.Shanghai Public Health Clinical Center and Institute of Biomedical Sciences,Fudan University,Shanghai,201508,China 8.Division of HIV/AIDS and Sex-Transmitted Virus Vaccines,National Institutes for Food and Drug Control,Beijing,China
First Author Affilication	School of Medicine; The Third People's Hospital of Shenzhen
Corresponding Author Affilication	School of Medicine; The Third People's Hospital of Shenzhen
Recommended Citation GB/T 7714	Ju，Bin,Zhang，Qi,Ge，Jiwan,et al. Human neutralizing antibodies elicited by SARS-CoV-2 infection[J]. NATURE,2020,584(7819):115-+.
APA	Ju，Bin.,Zhang，Qi.,Ge，Jiwan.,Wang，Ruoke.,Sun，Jing.,...&Zhang，Linqi.(2020).Human neutralizing antibodies elicited by SARS-CoV-2 infection.NATURE,584(7819),115-+.
MLA	Ju，Bin,et al."Human neutralizing antibodies elicited by SARS-CoV-2 infection".NATURE 584.7819(2020):115-+.

Files in This Item:
There are no files associated with this item.

If you have any objections to this item, please fill out the form below and the administrator will contact you as soon as possible.
Content:
Email：	*
Affiliation Sequential No:
Verification Code:	Refresh

Any comments and suggestions are welcomed.
Title:	*
Content:
Email：	*
Verification Code:	Refresh